HOLLI PFEIFER: Open Payments
NPI 1932413341 · BUCYRUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 45 payments from 14 companies in 2025. Trend: 2023 $45 · 2024 $258 · 2025 $807
Food & beverage: $807
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $193 |
| Novartis Pharmaceuticals Corporation | 5 | $122 |
| Novo Nordisk Inc | 7 | $115 |
| ABBVIE INC. | 5 | $99 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Amgen Inc. | 2 | $39 |
| Exact Sciences Corporation | 2 | $33 |
| Esperion Therapeutics, Inc. | 2 | $32 |
| Lilly USA, LLC | 2 | $30 |
| Currax Pharmaceuticals LLC | 2 | $30 |
Products named: LEQVIO, AIRSUPRA, Ozempic, VRAYLAR, FARXIGA, Kerendia, Cologuard Collection Kit, NEXLETOL.
Industry payments across OH — which companies pay providers there.
